TRANSMIT ENT (01326) announced that it may delay the publication of its 2024/2025 annual results. Should the company fail to publish its 2024/2025 annual results on or before September 30, 2025, the company's shares are expected to be suspended from trading on the Stock Exchange from 9:00 a.m. on October 2, 2025 (Thursday) until the company publishes its 2024/2025 annual results announcement.